From Concept to Congress: MAMMOKNIFE® ESTRO 2026 Launch

MAMMOKNIFE is currently in development. The device has not been cleared or approved by the U.S. Food and Drug Administration (FDA) and is not available for commercial use.

A Memorable Week at ESTRO

We marked an exciting milestone for our team as we officially unveiled MAMMOKNIFE.

After months of preparation it was incredibly rewarding to share our vision with the global radiation oncology community and introduce MAMMOKNIFE to so many passionate clinicians, researchers, and innovators dedicated to improving cancer care.

Throughout the week, we had the opportunity to meet people from around the world, exchange ideas, answer questions, and discuss the future of breast cancer treatment. The conversations were thoughtful, encouraging, and inspiring. Hearing firsthand about the challenges clinicians face every day reinforced why we started this journey and why innovation in this space matters.

What stood out most was the genuine interest and enthusiasm from those who stopped by to learn more. We are grateful to everyone who took the time to visit us, share feedback, and engage in meaningful discussions about the future of patient care.

This year was ESTRO’s largest congress yet with over 8,800+ attendees. Our symposium alone, “Prone Radiotherapy Modernized” where we shared the clinical need and design approach, attracted over 160 people.

ESTRO has always been a place where ideas, collaboration, and innovation come together, and we were honored to be part of this year’s congress. The experience provided not only an opportunity to showcase MAMMOKNIFE but also to build new relationships and connect with individuals who share our commitment to advancing breast cancer treatment.

As we reflect on the week, we are incredibly thankful for the support, encouragement, and new connections that came from this event.

While the unveiling was an important milestone, it is only the beginning.

We are excited about what lies ahead and look forward to continuing conversations with clinicians, researchers, collaborators, and future partners around the world.

Thank you to everyone who helped make our debut such a memorable experience!

Important Notice: MAMMOKNIFE is currently in development. The device has not been cleared or approved by the U.S. Food and Drug Administration (FDA) and is not available for commercial use.